Dr William M Marsh, MD in Wolfeboro, NH - Ophthalmology

Dr William M Marsh, MD is a Ophthalmology physician based in Wolfeboro, New Hampshire. Dr William M Marsh is licensed to practice in New Hampshire (license number 7228) and his current practice location is 10 Center Street, Wolfeboro, New Hampshire. He can be reached at his office (for appointments etc.) via phone at (603) 569-1550.

NPI number for Dr William M Marsh is 1568422343 and his current mailing address is 742 Pleasant Valley Rd, Wolfeboro, New Hampshire. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1568422343.

Contact Information

	Dr William M Marsh, MD
	10 Center Street, Wolfeboro, NH 03894
	(603) 569-1550
	Not Available

Physician's Profile

Full Name	Dr William M Marsh
Gender	Male
Speciality	Ophthalmology
Location	10 Center Street, Wolfeboro, New Hampshire
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1568422343
Provider Enumeration Date: 03/24/2006
Last Update Date: 06/25/2010

Medical Identifiers

Medical identifiers for Dr William M Marsh such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1568422343	NPI	-	NPPES
80007858	Medicaid	NH

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207W00000X	Ophthalmology	7228 (New Hampshire)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr William M Marsh is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr William M Marsh, MD 742 Pleasant Valley Rd, Wolfeboro, NH 03894-7120 Ph: (603) 569-6382	Dr William M Marsh, MD 10 Center Street, Wolfeboro, NH 03894 Ph: (603) 569-1550

News Archive

Blood-based test accurately identifies lung cancer patients who could benefit from immunotherapies

Researchers at UC Davis, Genentech and Foundation Medicine are the first to show that a blood-based test to assess tumor mutational burden accurately identifies non-small cell lung cancer (NSCLC) patients who could benefit from immunotherapies called checkpoint inhibitors.

Researchers identify mouse gene that reduces the accumulation Alzheimer's plaques and tangles

Investigators at Burnham Institute for Medical Research (Burnham) and colleagues have identified a novel mouse gene (Rps23r1) that reduces the accumulation of two toxic proteins that are major players in Alzheimer's disease: amyloid beta and tau. The amyloid and tau lowering functions of this gene were demonstrated in both human and mouse cells.

Roundup: Calif. insurer's Avastin decision; Kansas dental care; Gov. Brown vetoes nursing bill

Blue Shield of California will stop covering new Avastin prescriptions for breast cancer patients starting Oct. 17. Patients already on the drug will still be covered, and exceptions could be made for individual cases reviewed by a panel of cancer experts. The not-for-profit insurer cited an unprecedented vote by a U.S. Food and Drug Administration panel that found the drug was not effective enough against breast cancer to risk its potentially dangerous side effects.

Arthritis Foundation launches new initiatives on World Arthritis Day

The already staggering social and economic impact of arthritis in the United States is set to explode during the coming decades, says the Arthritis Foundation in response to a Centers for Disease Control and Prevention (CDC) report published in the Oct. 8 issue of Morbidity and Mortality Weekly Report, which coincides with World Arthritis Day on Tuesday, Oct. 12.

Dr William M Marsh, MD - Ophthalmology in Wolfeboro, NH